Botulism Antitoxin Bivalent (Equine) Types A and B.
Botulism Antitoxin Bivalent (Equine) Types A and B. is an FDA-licensed reference biologic from Sanofi Pasteur Limited. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2000
Reference approved
Reference product
Not listed Botulism Antitoxin Bivalent (Equine) Types A and B.
Sanofi Pasteur Limited
- Approved
- Feb 24, 2000
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Botulism Antitoxin Bivalent (Equine) Types A and B., in chronological order.
Reference approval
Approval date of the reference Botulism Antitoxin Bivalent (Equine) Types A and B. product.
26 yr 8 mo ago
Frequently asked questions
Are there biosimilars approved for Botulism Antitoxin Bivalent (Equine) Types A and B.?
No 351(k) biosimilars or interchangeable biosimilars referencing Botulism Antitoxin Bivalent (Equine) Types A and B. are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.